Members |
targetComponentId |
Hereditary disease |
Hereditary disease |
ärftligt syndrom med endoteliopati, retinopati, nefropati och stroke |
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
ärftlig methemoglobinemi, enzymatisk typ |
Autosomal recessive congenital methemoglobinemia (disorder) |
ärftlig icke-sfärocytär hemolytisk anemi orsakad av aldolas A-brist |
Glycogen storage disease due to aldolase A deficiency (disorder) |
ärftlig icke-sfärocytisk hemolytisk anemi orsakad av brist på NADH-methemoglobin-reduktas |
Autosomal recessive congenital methemoglobinemia (disorder) |
Hereditary progressive muscular dystrophy |
Muscular dystrophy |
ärftlig sensorisk och motorisk neuropati, typ V |
Hereditary motor and sensory neuropathy type 5 (disorder) |
ärftlig vaskulär retinopati |
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
Hermansky-Pudlack syndrome |
Hermansky-Pudlak syndrome |
heroin, icke läkemedel |
Diamorphine (substance) |
Herpailurus yaguarondi |
Puma yagouaroundi (organism) |
Herpes simplex with other specified complications |
Herpes simplex with complication |
Herpes simplex with unspecified complications |
Herpes simplex with complication |
Herpes zoster with other complications |
Herpes zoster with complication |
Herpes zoster with other nervous system complications |
Herpes zoster with nervous system complication |
sill eller strömming, livsmedel |
Herring (substance) |
Hetastarch 6% |
Hetastarch 60 mg/mL solution for injection |
hetastarch 6 %, infusionsvätska, lösning, flaska |
Hetastarch 60 mg/mL solution for injection |
Hetastarch 6g liquid |
Hetastarch 60 mg/mL solution for injection |
hydroxietylstärkelseallergi |
Non-allergic hypersensitivity to hetastarch (finding) |
Heteropagus |
Asymmetrical conjoined twins |
extrakt specifikt för hexahydroftalsyraanhydrid |
Hexahydrophthalic anhydride (substance) |
extrakt specifikt för hexametylendiisocyanat |
Hexamethylene diisocyanate (substance) |
hexastarch 6 %, infusionsvätska, lösning, flaska |
Product containing precisely hexastarch 60 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Hexosyltransferase |
Hexosyltransferase |
High risk non proliferative diabetic retinopathy |
Severe nonproliferative retinopathy due to diabetes mellitus (disorder) |
High risk of |
High risk of |
Hind brain contusion with open intracranial wound, unspecified state of consciousness |
Contusion of hindbrain with open intracranial wound (disorder) |
Hind brain contusion with open intracranial wound, with concussion, unspecified |
Contusion of hindbrain with open intracranial wound (disorder) |
Hind brain contusion with open intracranial wound, with loss of consciousness of unspecified duration |
Contusion of hindbrain with open intracranial wound (disorder) |
Hip DXA scan |
Dual energy X-ray absorptiometry of hip (procedure) |
Hip DXA scan |
Dual energy X-ray absorptiometry of hip (procedure) |
Hip dual energy X-ray absorptiometry scan (procedure) |
Dual energy X-ray absorptiometry of hip (procedure) |
poäng för höftfrakturrisk enligt WHO:s verktyg för skattning av frakturrisk, FRAX |
Hip fracture probability score using fracture risk assessment tool (observable entity) |
somatisk dysfunktion i höft |
Somatic dysfunction of hip region (finding) |
Hirundo fulva |
Petrochelidon fulva (organism) |
Hirundo pyrrhonota |
Cliff swallow |
histaminfosfat 275 mikrogram/ml, injektionsvätska, lösning, ampull |
Histamine only product in parenteral dose form |
histiocytär proliferation |
Histiocytic proliferation (morphologic abnormality) |
Histiocytoid hemangioma |
Epithelioid hemangioma |
histologisk grad |
Histologic grade (property) |
histologisk typ |
Histologic type (property) (qualifier value) |
anamnes: allergi mot ACE-hämmare |
H/O: angiotensin converting enzyme inhibitor pseudoallergy |
Hodgkins granulom [obs] |
Hodgkin granuloma |
Hodgkins lymfom, kategori |
Hodgkin lymphoma |
Hodgkins lymfom |
Hodgkin lymphoma |
Hodgkins sarkom [obs] |
Hodgkin sarcoma (morphologic abnormality) |
Hodgkin's disease, lymphocytic predominance |
Hodgkin lymphoma, lymphocyte-rich |
Hodgkin's disease, lymphocytic predominance, diffuse |
Hodgkin lymphoma, lymphocyte-rich |
Hodgkin's disease, nodular sclerosis, mixed cellularity |
Hodgkin lymphoma, nodular sclerosis, grade 1 (morphologic abnormality) |
Hodgkin's paragranuloma |
Hodgkin lymphoma, nodular lymphocyte predominance (clinical) |
Hodgkin's paragranuloma |
Hodgkin lymphoma, nodular lymphocyte predominance |
test av meningsläsning enligt Holborn |
Holborn Reading Scale (assessment scale) |
Holmes-Gangs syndrom |
X-linked intellectual disability hypotonic face syndrome |
homatropinhydrobromid 0,125 %, ögondroppar |
Product containing precisely homatropine hydrobromide 1.25 milligram/1 milliliter conventional release eye solution (clinical drug) |
homatropinhydrobromid 0,25 %, ögondroppar |
Homatropine hydrobromide 2.5 mg/mL eye solution |
homatropinhydrobromid 0,5 %, ögondroppar |
Homatropine hydrobromide 5 mg/mL eye solution |
homatropinhydrobromid 5 %, ögondroppar |
Homatropine hydrobromide 50 mg/mL eye solution |
Homatropine hydrobromide 5%/mL solution |
Homatropine hydrobromide 50 mg/mL eye solution |
ansvarig för hushållsarbetet (hemmafru) |
Home manager |
nebulisator använd i hemmet sedan förra besöket |
Home nebulizer used since last encounter |
Hongiella mannitolivorans |
Algoriphagus mannitolivorans (organism) |
Hordeolum internum |
Internal hordeolum (disorder) |
Hormone substitute |
Product containing hormone (product) |
vaccin mot hästallergi |
Horse allergy vaccine |
pepparrot, livsmedel |
Horseradish (substance) |
Horseradish - dietary |
Horseradish (substance) |
alopeci orsakat av hårstyling med väme |
Central centrifugal cicatricial alopecia (disorder) |
het miljö |
Hot environment |
khoikhoi |
Khoikhoi |
khoi |
Khoisan language |
vaccin mot husdammsallergi |
House dust allergy vaccine (product) |
vaccin mot husdammskvalster |
House mite allergy vaccine (product) |
antigen från humant adenovirus 40 |
Antigen of Human mastadenovirus F (substance) |
antigen från humant adenovirus 41 |
Antigen of Human mastadenovirus F (substance) |
alfa-1-antitrypsin 1000 mg, pulver till injektionsvätska, flaska |
Human alpha1 proteinase inhibitor 1 g powder for solution for injection vial |
alfa-1-antitrypsin 500 mg, injektionsvätska, lösning, flaska + spädningsvätska |
Human alpha1 proteinase inhibitor 500 mg powder for solution for injection vial |
humant alfa-1-antitrypsin 500 mg, pulver till injektionsvätska, lösning, flaska |
Human alpha1 proteinase inhibitor 500 mg powder for solution for injection vial |
humant koriongonadotropin, 10000 IE, pulver och vätska till injektionslösning, flaska |
Product containing precisely human chorionic gonadotropin 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
humant coronavirus, typ HK1 |
Human coronavirus HKU1 |
Human herpesvirus 1 group virus |
Simplexvirus |
Human herpesvirus 3 group virus |
Genus Varicellovirus (organism) |
humant immunbristvirus |
Human immunodeficiency virus Centers for Disease Control and Prevention stage 1 (finding) |
infektion orsakad av humant immunbristvirus (HIV) kategori B1 |
Human immunodeficiency virus Centers for Disease Control and Prevention stage 1 (finding) |
CDC-klassificering av HIV, kategori A1 |
Human immunodeficiency virus Centers for Disease Control and Prevention stage 1 (finding) |
CDC-klassificering av HIV, kategori B1 |
Human immunodeficiency virus Centers for Disease Control and Prevention stage 1 (finding) |
CDC-klassificering av HIV, kategori C1 (AIDS) |
Human immunodeficiency virus Centers for Disease Control and Prevention stage 1 (finding) |
WHO-klassificering av HIV, klass I |
World Health Organization 2007 Human immunodeficiency virus infection clinical stage 1 |
WHO-klassificering av HIV, klass II |
World Health Organization 2007 Human immunodeficiency virus infection clinical stage 2 |
WHO-klassificering av HIV, klass III |
World Health Organization 2007 Human immunodeficiency virus infection clinical stage 3 (finding) |
WHO-klassificering av HIV, klass IV (AIDS) |
World Health Organization 2007 Human immunodeficiency virus infection clinical stage 4 (finding) |
fynd som rör WHO-klassificering av HIV |
World Health Organization human immunodeficiency virus infection clinical stage (finding) |
medfödd HIV-positivitet |
HIV positive |
Human immunodeficiency virus type 2 |
Human immunodeficiency virus type 2 |
Human immunodeficiency virus type I |
Human immunodeficiency virus type I |
antikropp mot HIV-2 gp53 |
Human immunodeficiency virus 2 protein 53 antibody (substance) |
humant immunbristvirus-associerad parodontit |
Periodontitis exacerbated by human immunodeficiency virus infection (disorder) |
humant immunglobulin G 200 mg/ml, injektionsvätska, lösning |
Product containing only human immunoglobulin G (medicinal product) |
humant immunglobulin G 10 %, injektionsvätska, lösning, flaska |
Product containing only human immunoglobulin G (medicinal product) |
humant immunglobulin G 10 g, injektionsvätska, lösning, flaska |
Product containing only human immunoglobulin G (medicinal product) |
humant immunglobulin G 10 g, pulver till injektionsvätska, flaska |
Product containing only human immunoglobulin G (medicinal product) |